UCLA docs find success with TransMedics' tech; 510(k) changes could increase costs;

 @FierceMedDev: New special report: Top 10 Diagnostics Companies 2012. Report | Follow @FierceMedDev

@MarkHFierce: Venture funding lives: TriReme Medical pulled in $18 million in a new round. Release | Follow @MarkHFierce

 @DamianFierce: As Mindray Medical knows, being a Chinese company gives you cost advantages but can come with some PR hurdles. More | Follow @DamianFierce

> UCLA doctors, using TransMedics' technology, for the first time successfully kept donor lungs functioning and "breathing" in an Organ Care System device as they were transported for lung transplant into a 57-year-old patient with pulmonary fibrosis. Story

> Beyond the 2.3% device tax slated to begin in January, device companies will also confront new changes in the 510(k) clearance process and a number of increased costs, Becker's Spine Review reports. Story

> The Wall Street Journal reports on the push to develop medical device implants powered by the body's own energy. Story (sub. req.)

> The U.K. government has awarded funding for development of a simple cancer diagnostic that tests blood to determine in real time how well a patient responds to cancer treatment. Release

> CardioDx, a 2012 Fierce 15 company, is launching a large-scale trial to compare diagnostic solutions for patients with coronary artery disease symptoms. More

> GE Healthcare ($GE) got 510(k) clearance for its FlightPlan liver imaging system. Article

> The FDA has launched a handy website that tracks all of its MDUFA-related proposed guidances. Item

Biotech News

 @FierceBiotech: In case you missed it: Top 50 Industry Voices in Biotech Twittersphere -- 2012. Special Report | Follow @FierceBiotech

 @JohnCFierce: Updated Acadia story with CEO comments on pimavanserin dev plans. Confirm Ph3, pursue schizophrenia and Alzheimer's psychosis. Story | Follow @JohnCFierce

 @RyanMFierce: Why Big Data alone lacks the punch pharma needs. Article | Follow @RyanMFierce

> China fosters biosimilar drug R&D with new set of custom guidelines. More

> Pfizer gets Rhythm with $8M bet on diabetes, obesity drug work. News

Pharma News

@FiercePharma: Merck KGaA says it won't offload its consumer health unit, despite promise of big $$. Report | Follow @FiercePharma

> Abbott nabs new Humira use, launches Amitiza in Japan. News

> Sharpening Victoza's edge, Novo touts data in trial against Januvia, Byetta. More

Pharma Manufacturing News

> Some 'misbranded drugs' turned up in Avastin probe came from Roche plant. News

> Switzerland, home of Roche and Novartis, gets pass from EU API rule. Story

> EMA wants manufacturers to offer up drug shortage 'risk analysis'. Article

> Novartis gets FDA OK for faster flu vaccine production at U.S. plant. More

Biotech Research News

> German team combines 2 old drugs for new MS treatment. More

> Stem cell-reliant HIV vaccine launches animal studies in January. Article

> Anti-cancer virus could gain new power with patient immune cell tweak. Story

> McGill scientists link autistic behavior to brain protein mutation. Item

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.